HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulo Louzada-Junior Selected Research

Superoxides (Superoxide)

12/2020IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.
6/2008Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paulo Louzada-Junior Research Topics

Disease

14Rheumatoid Arthritis
07/2023 - 02/2008
13COVID-19
12/2023 - 01/2021
10Arthritis (Polyarthritis)
04/2024 - 06/2008
10Inflammation (Inflammations)
04/2024 - 09/2010
8Infections
03/2024 - 12/2007
8Psychotic Disorders (Schizoaffective Disorder)
02/2024 - 08/2012
5Rheumatic Diseases (Rheumatism)
03/2020 - 05/2012
4Experimental Arthritis
12/2021 - 05/2012
4Necrosis
03/2021 - 07/2009
3Osteoarthritis
07/2023 - 01/2018
3Schizophrenia (Dementia Praecox)
12/2022 - 01/2018
3Gout
12/2020 - 01/2016
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2018 - 09/2009
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2012 - 06/2008
2Neoplasms (Cancer)
01/2022 - 08/2012
2Sacroiliitis
01/2022 - 10/2020
2Ankylosing Spondylitis
01/2022 - 05/2015
2Leprosy (Hansen's Disease)
01/2018 - 10/2010
2Multiple Sclerosis
01/2010 - 09/2007
1Cross Infection (Nosocomial Infection)
01/2023
1Hyperglycemia
01/2023
1Bacteremia
01/2023
1Pneumonia (Pneumonitis)
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Cadaver (Cadavers)
01/2022
1Lymphopenia (Lymphocytopenia)
07/2021
1Wounds and Injuries (Trauma)
01/2021
1Mental Disorders (Mental Disorder)
01/2021

Drug/Important Bio-Agent (IBA)

12CytokinesIBA
04/2024 - 10/2015
7AntigensIBA
04/2024 - 12/2007
7Interleukin-6 (Interleukin 6)IBA
01/2023 - 10/2015
7AntibodiesIBA
03/2021 - 02/2008
5Biomarkers (Surrogate Marker)IBA
07/2023 - 02/2015
4Polytetrafluoroethylene (Teflon)FDA Link
02/2024 - 01/2020
4InflammasomesIBA
01/2023 - 01/2021
4Interleukin-33IBA
01/2023 - 09/2010
4Antirheumatic Agents (DMARD)IBA
03/2020 - 07/2009
4Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 09/2010
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024 - 08/2012
3Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2022
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2023 - 01/2021
3Interleukin-10 (Interleukin 10)IBA
01/2023 - 10/2015
3Uric Acid (Urate)IBA
12/2020 - 01/2016
3Infliximab (Remicade)FDA Link
01/2017 - 09/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 09/2010
2ametantrone (HAQ)IBA
03/2024 - 05/2011
2NucleotidesIBA
05/2023 - 05/2012
2Interleukin-18 (Interleukin 18)IBA
01/2023 - 01/2021
2InterleukinsIBA
12/2022 - 03/2021
2Double-Stranded RNA (RNA, Double Stranded)IBA
01/2022 - 08/2020
2C-Reactive ProteinIBA
01/2022 - 07/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 10/2017
2InterferonsIBA
03/2021 - 01/2018
2SmokeIBA
01/2021 - 01/2018
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 12/2014
2Superoxides (Superoxide)IBA
12/2020 - 06/2008
2Interleukin-17 (Interleukin 17)IBA
01/2018 - 05/2012
2Tumor Necrosis Factor InhibitorsIBA
01/2017 - 08/2012
2Rituximab (Mabthera)FDA Link
01/2017 - 02/2013
2VaccinesIBA
02/2013 - 12/2007
2Rheumatoid FactorIBA
10/2012 - 05/2011
2Anti-Citrullinated Protein AntibodiesIBA
10/2012 - 05/2011
2cyclic citrullinated peptideIBA
05/2011 - 07/2009
2Antiphospholipid AntibodiesIBA
10/2010 - 09/2009
2EpitopesIBA
07/2009 - 02/2008
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
04/2024
1ResistinIBA
04/2024
1AdipokinesIBA
04/2024
1CAP1-6DIBA
04/2024
1Anti-Bacterial Agents (Antibiotics)IBA
03/2024
1Enoxaparin (Lovenox)FDA LinkGeneric
12/2023
1AnticoagulantsIBA
12/2023
1SurvivinIBA
07/2023
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2023
1Complement C5a (Complement 5a)IBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1HMGB1 Protein (HMG1)IBA
01/2023
1Blood Glucose (Blood Sugar)IBA
01/2023
1Psychotropic Drugs (Psychoactive Drugs)IBA
12/2022
1Immunomodulating AgentsIBA
01/2022
1Viral RNAIBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1Mitochondrial DNA (mtDNA)IBA
01/2022
1Disulfiram (Antabuse)FDA Link
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1acetyl 4-aminosalicylic acidIBA
12/2021
1Fibrinogen (Factor I)FDA Link
12/2021
1fibrin fragment D (D-dimer)IBA
07/2021
1Ferritins (Ferritin)IBA
07/2021
1Heparin (Liquaemin)FDA LinkGeneric
07/2021
1Interleukin-4 (Interleukin 4)IBA
03/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2021
1Immunoglobulin G (IgG)IBA
03/2021
1ColchicineFDA LinkGeneric
01/2021
1Messenger RNA (mRNA)IBA
01/2021

Therapy/Procedure

7Therapeutics
11/2021 - 09/2010
3Biological Therapy
03/2020 - 05/2015
1Artificial Respiration (Mechanical Ventilation)
01/2023
1Palliative Care (Palliative Therapy)
01/2022